phase readout
saveNCT04685590: Senolytic Therapy to Modulate the Progression of Alzheimer's Disease (SToMP-AD) Study
ACTIVE_NOT_RECRUITINGupdated 1mo ago
community read0 votes
Sponsor: Washington University School of Medicine. Phase: PHASE2. Conditions: Alzheimer Disease, Early Onset, Mild Cognitive Impairment
view source ↗
comments(0)
5-min edit window · permanent after that